COVID Vaccine BLA Review ‘Sprint’: Elevating Marks Role Could Have Drawbacks

 
• By Sarah Karlin-Smith
sprinter
FDA is kicking off a sprint to finish reviewing Pfizer’s COVID-19 vaccine BLA. • Source: Alamy

More from Vaccines

More from Pink Sheet